Ten-year subtype survival and systemic-therapy pathways analysis after breast-cancer recurrence in the LACRN MPBC multicountry cohort study.
Retamales J, Araya I, Abdelhay E, Acosta Torres KT, Alves da Quinta D, Alcoba E, Alonso I, Artagaveytia N, Binato R, Bravo AI, Bustos-Rodriguez F, Camejo N, Carraro DM, Castro M, Cataldi S, Cerda M, Chiquitelli Marques Silveira MM, Crocamo S, Daneri-Navarro A, Del Toro-Arreola A, Franco-Topete R, Gaete F, Gomez J, Guerra R, Hannois A, Llera AS, Lopez-Vazquez A, Moran-Mendoza A, Nagai MA, Oceguera-Villanueva A, Podhajcer O, Quintero-Ramos A, Rosales C, Saavedra E, Seguel O, Sierra C, Sanchotena V, Savignano M, Tejeda-Moctezuma R, Trinchero A, Valenzuela B, Velazquez C, Villalobos M, Vilensky M, Zagame L, Zlatar Z, Müller B; Latin American Cancer Research Network (LACRN) Investigators.
Retamales J, et al.
Lancet Reg Health Am. 2026 Apr 30;59:101485. doi: 10.1016/j.lana.2026.101485. eCollection 2026 Jul.
Lancet Reg Health Am. 2026.
PMID: 42095205
Free PMC article.